Menu

Adamas Pharmaceuticals, Inc. ADMS

Full chart Compare
Set alert

Price alert · ADMS

All alert types
8.22 0.00 (+0.00%)

Apr 24, 2025, 3:47 PM EDT

8.18 Day range 8.25

52-week range unavailable

Revenue & Expenses

Revenue by
Product → Revenue: $71.17MRevenue → Gross Profit: $72.42MGross Profit → Expenses: $72.42MRevenue → Cost of Revenue: $2.04MExpenses → Selling, General & Admin: $106.84MExpenses → Research & Development: $9.75MExpenses → Interest Expense: $13.24MRoyalty → Revenue: $3.29MNet Loss → Expenses: $57.40MGross Profit$72.42MNet Loss$57.40MCost of Revenue$2.04MExpenses$129.83MSelling, General & Admin$106.84MResearch & Development$9.75MInterest Expense$13.24MRevenue$74.46MProduct$71.17MRoyalty$3.29M

Latest period ending Dec 31, 2020 · select a line to chart its full history

Annual income statement

ADMS annual income statement
Fiscal yearFY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017FY 2016 Dec 31, 2016
74.46M54.64M34.05M571.00K572.00K
74.46M54.64M34.05M571.00K572.00K
2.04M2.47M633.00K17.00K0
72.42M52.17M33.41M554.00K572.00K
116.59M144.40M148.44M88.48M61.56M
9.75M30.03M39.30M27.17M31.23M
106.84M114.37M109.14M61.31M30.33M
-44.16M-92.23M-115.02M-87.93M-60.98M
13.99M15.04M19.09M4.64M0
-57.40M-105.19M-131.00M-89.49M-60.06M
-57.40M-105.19M-131.00M-89.49M-60.06M
-57.40M-105.19M-131.00M-89.49M-60.06M
-57.40M-105.19M-131.00M-89.49M-60.06M
-2.03-3.80-4.87-3.97-2.77
-2.03-3.80-4.87-3.97-2.77
-2.03-3.80-4.87-3.97-2.77
-43.42M-90.14M-111.91M-86.58M-60.17M
-43.42M-90.14M-111.91M-86.58M-60.17M
28.30M27.68M26.89M22.56M21.71M
28.30M27.68M26.89M22.56M21.71M